Nodality, Inc.

26 articles about Nodality, Inc.

• Nodality, Inc. Appoints Kathleen LaPorte As Chief Executive Officer

  7/8/2015

• Nodality, Inc. Launches Pathpro T Cell Receptor (TCR) And B Cell Receptor (BCR) Panels For Assessing Drug Impact On Functional Signaling In Primary Human Cells

  5/6/2015

• Nodality, Inc. Publishes Study Results Confirming The Company’s Diagnostic Can Predict Induction Therapy Response In Elderly Patients With Acute Myeloid Leukemia

  4/21/2015

• Nodality, Inc. Launches PathPro Chronic Lymphocytic Leukemia (CLL) Panels Based On Leading Single Cell Network Profiling (SCNPTM) Platform To Enhance Pharmaceutical R&D

  4/3/2015

• Nodality, Inc. Presents Data From Immuno-Oncology Program Applying Company’s Novel Single Cell Network Profiling (SCNP) Platform

  2/25/2015

• Nodality, Inc. Launches Pathpro™ Product Line Based On Leading Single Cell Network Profiling (SCNPTM) Platform To Enhance Pharmaceutical R&D

  1/7/2015

• Nodality, Inc. Develops Disease-Associated PD-1 Assay System For Application In Immuno-oncology

  11/19/2014

• Nodality, Inc. Announces Data Presentation From Collaborative Program With UCB Pharma At American College of Rheumatology 2014 Annual Meeting

  11/18/2014

• Nodality, Inc. Announces Data Presentations From Systemic Lupus Erythematosus Collaborative Programs At American College of Rheumatology 2014 Annual Meeting

  11/17/2014

• Nodality, Inc. Expands Intellectual Property Estate, Announces U.S. Patent For Broadly Enabling Single Cell Network Profiling (SCNP) Technology Platform

  8/14/2014

• Nodality, Inc. Announces Publication Of Promising Data In Melanoma In Journal Of Translational Medicine

  5/28/2014

• Nodality, Inc. Appoints Ralph Snyderman, M.D., To Board Of Directors

  2/26/2014

• Nodality, Inc. Enters Into A Strategic Collaboration With Johnson & Johnson Innovation In Autoimmune Diseases

  1/8/2014

• Nodality, Inc. To Present At The Oppenheimer 24th Annual Healthcare Conference

  12/6/2013

• Nodality, Inc. Announces Presentations At The 28th Annual Meeting Of The Society For Immunotherapy Of Cancer (SITC)

  11/12/2013

• Nodality, Inc. Announces Presentations at 2013 American College of Rheumatology Annual Meeting

  10/28/2013

• Nodality, Inc. Reports Promising Rheumatoid Arthritis Study Results to Predict Patient Treatment Response to TNF Inhibitors

  8/26/2013

• Nodality, Inc. Announces Data Presentations at American Association for Cancer Research 2013 Annual Meeting

  4/11/2013

• Nodality, Inc. Announces Expansion of Company's Patent Estate Covering Programs to Improve the Treatment of Patients With Severe Diseases in Immunology, Oncology, and Autoimmune Diseases

  4/10/2013

• Nodality, Inc. Appoints Laura Brege as Chief Executive Officer

  9/24/2012